FTC and FDA drive against Internet drugs

30 October 2006

A multi-agency drive by the US Food and Drug Administration, the Federal Trade Commission and equivalent governmental departments in neighboring Canada and Mexico has been launched to stop the fraudulent or misleading promotion of diabetes remedies that are sold over the Internet.

"Be smart, be skeptical" on-line

Lydia Parnes, Director of the FTC's Bureau of Consumer Protection, in a statement, said: "the Internet can be a great source of information, but it also is a billboard for ads that promise miracle cures for diabetes and other serious diseases. Our advice to consumers: 'Be smart, be skeptical' when evaluating health claims on-line."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight